UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number:    000-21699
 
ViroPharma Incorporated
(Exact name of registrant as specified in its charter)

730 Stockton Drive
Exton, Pennsylvania 19341
(610) 458-7300
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Class A Common Stock, par value $0.002 per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
 
x
Rule 12g-4(a)(2)
 
¨
Rule 12h-3(b)(1)(i)
 
x
Rule 12h-3(b)(1)(ii)
 
¨
Rule 15d-6
 
¨
 
Approximate number of holders of record as of the certification or notice date:  1
 
Pursuant to the requirements of the Securities Exchange Act of 1934 ViroPharma Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
 
Date:  February 4, 2014   
ViroPharma Incorporated
 
             
             
             
    By: /s/ Ellen Rosenberg  
        Name: Ellen Rosenberg  
        Title: Secretary    
 
 
 
 
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Viropharma Incorporated (MM) Charts.
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Viropharma Incorporated (MM) Charts.